Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrea Knight

Showing results (1-10 of 53) with videos related to

Pageof 6
Sort By:
Biochimie|May 13, 2022
Cryptic inhibitory regions nearby activation domainsAndrea Knight, Martin Piskacek
Cytotherapy|July 18, 2012
Human Vdelta1 gamma-delta T cells exert potent specific cytotoxicity against primary multiple myeloma cellsAndrea Knight, Stephen Mackinnon, Mark W Lowdell
Plos One|January 6, 2017
The 9aaTAD Is Exclusive Activation Domain in Gal4Martin Piskacek, Marek Havelka, Martina Rezacova, et al.
The Journal of Steroid Biochemistry and Molecular Biology|November 24, 2018
Nuclear hormone receptors: Ancient 9aaTAD and evolutionally gained NCoA activation pathwaysMartin Piskacek, Marek Havelka, Kristina Jendruchova, et al.
The Biochemical Journal|February 24, 2023
The NFkB activation domain is 14-amino-acid-long variant of the 9aaTADJosef Houser, Kristina Jendruchova, Andrea Knight, et al.
Plos One|September 13, 2016
The 9aaTAD Transactivation Domains: From Gal4 to p53Martin Piskacek, Marek Havelka, Martina Rezacova, et al.
Molecular Biosystems|January 8, 2015
Shared structural features of the 9aaTAD family in complex with CBPMartin Piskacek, Anna Vasku, Roman Hajek, et al.
Frontiers in Immunology|October 25, 2021
Blocking of EphA2 on Endometrial Tumor Cells Reduces Susceptibility to Vδ1 Gamma-Delta T-Cell-Mediated KillingRobert Hudecek, Barbora Kohlova, Ingrid Siskova, et al.
Cellular and Molecular Life Sciences : CMLS|August 4, 2019
The evolution of the 9aaTAD domain in Sp2 proteins: inactivation with valines and intron reservoirsMartin Piskacek, Marek Havelka, Kristina Jendruchova, et al.
Brain, Behavior, and Immunity|January 18, 2014
Reduced thymic output in elite athletesAdria Prieto-Hinojosa, Andrea Knight, Claude Compton, et al.
Pageof 6

Showing results (1-10 of 53) with videos related to

Sort By:
Pageof 6
Biochimie|May 13, 2022
Cryptic inhibitory regions nearby activation domainsAndrea Knight, Martin Piskacek
Cytotherapy|July 18, 2012
Human Vdelta1 gamma-delta T cells exert potent specific cytotoxicity against primary multiple myeloma cellsAndrea Knight, Stephen Mackinnon, Mark W Lowdell
Plos One|January 6, 2017
The 9aaTAD Is Exclusive Activation Domain in Gal4Martin Piskacek, Marek Havelka, Martina Rezacova, et al.
The Journal of Steroid Biochemistry and Molecular Biology|November 24, 2018
Nuclear hormone receptors: Ancient 9aaTAD and evolutionally gained NCoA activation pathwaysMartin Piskacek, Marek Havelka, Kristina Jendruchova, et al.
The Biochemical Journal|February 24, 2023
The NFkB activation domain is 14-amino-acid-long variant of the 9aaTADJosef Houser, Kristina Jendruchova, Andrea Knight, et al.
Plos One|September 13, 2016
The 9aaTAD Transactivation Domains: From Gal4 to p53Martin Piskacek, Marek Havelka, Martina Rezacova, et al.
Molecular Biosystems|January 8, 2015
Shared structural features of the 9aaTAD family in complex with CBPMartin Piskacek, Anna Vasku, Roman Hajek, et al.
Frontiers in Immunology|October 25, 2021
Blocking of EphA2 on Endometrial Tumor Cells Reduces Susceptibility to Vδ1 Gamma-Delta T-Cell-Mediated KillingRobert Hudecek, Barbora Kohlova, Ingrid Siskova, et al.
Cellular and Molecular Life Sciences : CMLS|August 4, 2019
The evolution of the 9aaTAD domain in Sp2 proteins: inactivation with valines and intron reservoirsMartin Piskacek, Marek Havelka, Kristina Jendruchova, et al.
Brain, Behavior, and Immunity|January 18, 2014
Reduced thymic output in elite athletesAdria Prieto-Hinojosa, Andrea Knight, Claude Compton, et al.
Pageof 6